A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups

World Health Organization. Recommended viruses for influenza vaccines for use in the 2010–2011 northern hemisphere influenza season: frequently asked questions. Geneva; 2010. p. 1–4. http://www.who.int/csr/disease/influenza/201002_RecommendationFAQ.pdf. Jefferson, 2010, Vaccines for preventing influenza in healthy adults, Cochrane Database Syst Rev, 10.1002/14651858.CD001269.pub4 Nichol, 2008, Efficacy and effectiveness of influenza vaccination, Vaccine, 26S, D17, 10.1016/j.vaccine.2008.07.048 Couch, 2008, Seasonal inactivated influenza virus vaccines, Vaccine, 26S, D5, 10.1016/j.vaccine.2008.05.076 Hehme, 2002, Ten years of experience with the trivalent split-influenza vaccine, Fluarix, Clin Drug Invest, 22, 751, 10.2165/00044011-200222110-00004 Monto, 2010, Seasonal influenza vaccinations: specialized products for different target groups, Vaccine, 28, D14, 10.1016/j.vaccine.2010.08.025 Simonsen, 2009, Influenza vaccination and mortality benefits: new insights, new opportunities, Vaccine, 27, 6300, 10.1016/j.vaccine.2009.07.008 Nicoll, 2008 Fiore, 2010, Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep, 59, 1 Comité voor de Evaluatie van de Medische Praktijk inzake Geneesmiddelen (CEG)[[nl]]Committee for the evaluation of medical practice, 2010 Shea, 2009, AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews, J Clin Epidemiol, 62, 1013, 10.1016/j.jclinepi.2008.10.009 Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.0.2 [updated September 2009]. The Cochrane Collaboration: www.cochrane-handbook.org; 2009. Atkins, 2004, Grading quality of evidence and strength of recommendations, BMJ, 328, 1490, 10.1136/bmj.328.7454.1490 Guyatt, 2008, GRADE: an emerging consensus on rating quality of evidence and strength of recommendations, BMJ, 336, 924, 10.1136/bmj.39489.470347.AD Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, BMJ, 339, b2535, 10.1136/bmj.b2535 Jadad, 1996, Assessing the quality of reports of randomised controlled trials: is blinding necessary?, Controlled Clin Trials, 17 Thomas, 2010, Influenza vaccination for healthcare workers who work with the elderly, Cochrane Database Syst Rev, 10.1002/14651858.CD005187.pub3 Cheuk, 2011, Vaccines for prophylaxis of viral infections in patients with hematological malignancies, Cochrane Database Syst Rev, 10.1002/14651858.CD006505.pub2 Anema, 2008, Efficacy of influenza vaccination in HIV-positive patients: a systematic review and meta-analysis, HIV Med, 9, 57, 10.1111/j.1468-1293.2008.00515.x Monto, 2009, Comparative efficacy of inactivated and live attenuated influenza vaccines, N Engl J Med, 361, 1260, 10.1056/NEJMoa0808652 Ohmit, 2006, Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines, N Engl J Med, 355, 2513, 10.1056/NEJMoa061850 Ohmit, 2008, Prevention of symptomatic seasonal influenza in 2005–2006 by inactivated and live attenuated vaccines, J Infect Dis, 198, 312, 10.1086/589885 Madhi, 2011, Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety, Clin Infect Dis, 52, 128, 10.1093/cid/ciq004 Jansen, 2008, Effects of influenza plus pneumococcal conjugate vaccination versus influenza vaccination alone in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled trial, J Pediatr, 153, 764, 10.1016/j.jpeds.2008.05.060 Zaman, 2008, Effectiveness of maternal influenza immunization in mothers and infants, N Engl J Med, 359, 1555, 10.1056/NEJMoa0708630 Barrett, 2011, Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial, Lancet, 377, 751, 10.1016/S0140-6736(10)62228-3 Frey, 2010, Clinical efficacy of cell culture-derived and egg-derived inactivated subunit influenza vaccines in healthy adults, Clin Infect Dis, 51, 997, 10.1086/656578 Jackson, 2010, Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons, BMC Infect Dis, 10, 71, 10.1186/1471-2334-10-71 Loeb, 2010, Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial, JAMA, 303, 943, 10.1001/jama.2010.250 Hui, 2008, Effectiveness of influenza vaccine in preventing influenza-like illness among Faculty of Dentistry staff and students in University Kebangsaan Malaysia, Healthc Infect, 13, 4, 10.1071/HI08003 Marchisio, 2009, Efficacy of injectable trivalent virosomal-adjuvanted inactivated influenza vaccine in preventing acute otitis media in children with recurrent complicated or noncomplicated acute otitis media, Pediatr Infect Dis J, 28, 855, 10.1097/INF.0b013e3181a487b4 Phrommintikul, 2011, Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome, Eur Heart J, 10.1093/eurheartj/ehr004 Song, 2007, Clinical impact of influenza immunization in patients with liver cirrhosis, J Clin Virol, 39, 159, 10.1016/j.jcv.2007.04.018 Anar, 2010, Evaluation of clinical data and antibody response following influenza vaccination in patients with chronic obstructive pulmonary disease, New Microbiol, 33, 117 Michiels, 2006, The effect of giving influenza vaccination to general practitioners: a controlled trial [NCT00221676], BMC Med, 4, 17, 10.1186/1741-7015-4-17 Ochiai, 2009, Inactivated influenza vaccine effectiveness against influenza-like illness among young children in Japan--with special reference to minimizing outcome misclassification, Vaccine, 27, 7031, 10.1016/j.vaccine.2009.09.067 Jefferson, 2008, Vaccines for preventing influenza in healthy children, Cochrane Database Syst Rev, 10.1002/14651858.CD004879.pub3 Jefferson, 2010, Vaccines for preventing influenza in the elderly, Cochrane Database Syst Rev, 2, CD004876 Poole, 2006, Influenza vaccine for patients with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 10.1002/14651858.CD002733.pub2 Cates, 2008, Vaccines for preventing influenza in people with asthma, Cochrane Database Syst Rev, 10.1002/14651858.CD000364.pub3 Chang, 2007, Influenza vaccine for children and adults with bronchiectasis, Cochrane Database Syst Rev, 10.1002/14651858.CD006316.pub2 Dharmaraj, 2009, Vaccines for preventing influenza in people with cystic fibrosis, Cochrane Database Syst Rev, CD001753 Keller, 2008, Influenza vaccines for preventing coronary heart disease, Cochrane Database Syst Rev, 10.1002/14651858.CD005050.pub2 Goossen, 2009, Influenza vaccination in children being treated with chemotherapy for cancer, Cochrane Database Syst Rev, 10.1002/14651858.CD006484.pub2 van der Wouden, 2005, Preventing influenza: an overview of systematic reviews, Respir Med, 99, 1341, 10.1016/j.rmed.2005.07.001 Ambrose, 2010, The efficacy of live attenuated and inactivated influenza vaccines in children as a function of time postvaccination, Pediatr Infect Dis J, 29, 806, 10.1097/INF.0b013e3181e2872f Seidman, 2011, Quantitative review of antibody response to inactivated seasonal influenza vaccines, Influenza Other Respir Viruses Belshe, 2007, Live attenuated versus inactivated influenza vaccine in infants and young children, N Engl J Med, 356, 685, 10.1056/NEJMoa065368 Vesikari, 2009, Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant, Pediatr Infect Dis J, 28, 563, 10.1097/INF.0b013e31819d6394 Glezen, 2006, Commentary: benefits of influenza vaccine in US elderly-new studies raise questions, Int J Epidemiol, 35, 352, 10.1093/ije/dyi293 Simonsen, 2005, Impact of influenza vaccination on seasonal mortality in the US elderly population, Arch Intern Med, 165, 265, 10.1001/archinte.165.3.265 Eurich, 2008, Mortality reduction with influenza vaccine in patients with pneumonia outside flu season: pleiotropic benefits or residual confounding?, Am J Respir Crit Care Med (United States), 178, 527, 10.1164/rccm.200802-282OC Jackson, 2006, Evidence of bias in estimates of influenza vaccine effectiveness in seniors, Int J Epidemiol, 35, 337, 10.1093/ije/dyi274 Nichol, 2007, Effectiveness of influenza vaccine in the community-dwelling elderly, N Engl J Med, 357, 1373, 10.1056/NEJMoa070844 Hak, 2006, Benefits of influenza vaccine in US elderly – appreciating issues of confounding bias and precision, Int J Epidemiol, 35, 800, 10.1093/ije/dyl068 Simonsen, 2007, Mortality benefits of influenza vaccination in elderly people: an ongoing controversy, Lancet Infect Dis, 7, 658, 10.1016/S1473-3099(07)70236-0 Baxter, 2010, Evidence of bias in studies of influenza vaccine effectiveness in elderly patients, J Infect Dis, 201, 186, 10.1086/649568 Xing, 2009, Meta analysis on the effectiveness of inactivated influenza vaccine, Zhonghua Liu Xing Bing Xue Za Zhi, 30, 368 Petrie, 2011, Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures, J Infect Dis, 203, 1309, 10.1093/infdis/jir015 Hoge gezondheidsraad [High Council of Health]. Vaccinatie tegen seizoensgebonden griep Winterseizoen 2010–2011 [Vaccination against seasonal influenza – season 2010–2011], vol. 8682. Brussel; 2010. http://www.zorg-en-gezondheid.be/griep.aspx#TOP. World Health Organization, 2000, Influenza vaccines: recommendations for the use of inactivated influenza vaccines and other preventive measures, Weekly Epidemiol Rec, 75, 281 Fireman, 2009, Influenza vaccination and mortality: differentiating vaccine effects from bias, Am J Epidemiol, 170, 650, 10.1093/aje/kwp173 Baxter, 2010, Effect of influenza vaccination on hospitalizations in persons aged 50 years and older, Vaccine, 28, 7267, 10.1016/j.vaccine.2010.08.088 Jackson, 2008, Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case–control study, Lancet, 372, 398, 10.1016/S0140-6736(08)61160-5 Scuffham, 2002, Economic evaluation of strategies for the control and management of influenza in Europe, Vaccine, 20, 2562, 10.1016/S0264-410X(02)00154-8 Guyatt, 2011, GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables, J Clin Epidemiol, 64, 383, 10.1016/j.jclinepi.2010.04.026 Guyatt, 2008, Going from evidence to recommendations, BMJ, 336, 1049, 10.1136/bmj.39493.646875.AE Newall, 2009, Cost effectiveness of influenza vaccination in older adults: a critical review of economic evaluations for the 50- to 64-year age group, Pharmacoeconomics, 27, 439, 10.2165/00019053-200927060-00001 Brożek, 2011, Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations, Allergy, 66, 588, 10.1111/j.1398-9995.2010.02530.x Rimmelzwaam, 2008, Correlates of protection: novel generations of influenza vaccines, Vaccine, 26S, D41, 10.1016/j.vaccine.2008.07.043 Thomas, 2010, Influenza vaccination for healthcare workers who work with the elderly: systematic review, Vaccine, 29, 344, 10.1016/j.vaccine.2010.09.085